Climb Bio

Climb Bio

MA - Wellesley Hills
Biotechnology

Focus: Treatments for neuronal Excitability Disorders

Climb Bio is a life sciences company focused on Treatments for neuronal Excitability Disorders.

Oncology
Open Jobs
2

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT07090655A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy Volunteers
Phase 1
Phase 1
Clinical Trials (1)
NCT07248865A Phase 1 Study of CLYM116 in Normal Healthy Volunteers
Phase 1
Clinical Trials (1)
NCT07011043A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
Phase 1
Clinical Trials (1)
NCT07043946A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)
Phase 1/2
Clinical Trials (1)
NCT07096843A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Phase 2

Open Jobs (2)

Interview Prep Quick Facts
Portfolio: 5 clinical trials
Open Roles: 2 active jobs

Hiring Trend

Stable
2
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles